Study of BL-M05D1 for advanced solid tumors
Treatments studied
Part of Cancer clinical trials.
This study tests a new drug called BL-M05D1 for people with advanced or metastatic solid tumors that have stopped responding to standard treatments. It aims to see if the drug is safe and effective.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 75 years old.
- You have advanced or metastatic solid tumors that have not responded to or cannot be treated with standard therapies.
- You are willing to provide a tumor tissue sample from a previous biopsy or surgery (within 3 years).
- You have at least one tumor that can be measured on scans (like a CT scan).
- You are in good physical condition (ECOG score 0 or 1) and expected to live at least 3 months.
- You have no serious heart, lung, or bleeding problems, and no active infections or other cancers.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new drug called BL-M08D for people with advanced solid tumors, especially those in the digestive tract (like stomach, colon, or pancreas). The goal is to see if it is safe and effective, and it might help shrink tumors or slow their growth.
This trial is testing a new drug called BL-M08D for people with melanoma or other solid tumors that have spread. The drug aims to attack cancer cells, and researchers want to see if it is safe and effective.
This study tests a new antibody drug (BL-M05D1) for advanced stomach or lower esophagus cancer that did not respond to first-line chemotherapy. The drug targets a protein called claudin 18.2 found on some cancer cells and may help slow or shrink the cancer.
This trial tests a new drug, BL-M24D1, in people with advanced or metastatic digestive tract cancers or other solid tumors that have not responded to standard treatments. The goal is to see if it is safe and effective.
This trial tests an experimental drug called BL-M08D1 for people with solid tumors that have spread or cannot be removed by surgery and have stopped responding to standard treatments. The goal is to see if the drug is safe and effective.
This trial tests a new drug, BL-M09D1, in people with advanced non-small cell lung cancer or other solid tumors that have not responded to standard treatments. The goal is to see if the drug can help shrink or control the cancer.
Hear when a new Locally Advanced or Metastatic Solid Tumors trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.